IL-2 mRNA stabilization upon PMA stimulation is dependent on NF90-Ser 647 phosphorylation by protein kinase CβI

Journal of Immunology

Volumn 185, Issue 9, 2010, Pages 5140-5149

  Zhu, Ping ^a   Jiang, Wei ^a   Cao, Lihuan ^a   Yu, Wenbo ^a   Pei, Yuan ^a   Yang, Xianmei ^a   Wan, Bo ^a   Liu, Jun O ^b   Yi, Qing ^c   Yu, Long ^a  

^a FUDAN UNIVERSITY   (China)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN ENHANCER BINDING FACTOR 3; MESSENGER RNA; PHORBOL ESTER; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA I; SERINE; UNCLASSIFIED DRUG; ILF3 PROTEIN, HUMAN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOPLASM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RNA STABILITY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION; CELL LINE; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; IMMUNOPRECIPITATION; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL LINE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPRECIPITATION; INTERLEUKIN-2; JURKAT CELLS; LYMPHOCYTE ACTIVATION; NUCLEAR FACTOR 90 PROTEINS; PHOSPHORYLATION; PROTEIN KINASE C; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA STABILITY; RNA, MESSENGER; SERINE; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION;

EID: 78149483844     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000849     Document Type: Article

References (50)

1. Crabtree, G. R. 1989. Contingent genetic regulatory events in T lymphocyte activation. Science 243:355-361.
2. Caput, D., B. Beutler, K. Hartog, R. Thayer, S. Brown-Shimer, and A. Cerami. 1986. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83:1670-1674.
3. Chen, C. Y., and A. B. Shyu. 1995. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20:465-470.
4. Lindstein, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339-343.
5. Stoecklin, G., S. Hahn, and C. Moroni. 1994. Functional hierarchy of AUUUA motifs in mediating rapid interleukin-3 mRNA decay. J. Biol. Chem. 269:28591-28597.
6. Brennan, C. M., and J. A. Steitz. 2001. HuR and mRNA stability. Cell. Mol. Life Sci. 58:266-277.
7. Carballo, E., W. S. Lai, and P. J. Blackshear. 1998. Feedback inhibition of macrophage tumor necrosis factor-a production by tristetraprolin. Science 281:1001-1005.
8. Chen, C. Y., R. Gherzi, S. E. Ong, E. L. Chan, R. Raijmakers, G. J. Pruijn, G. Stoecklin, C. Moroni, M. Mann, and M. Karin. 2001. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 107:451-464.
9. Schmidlin, M., M. Lu, S. A. Leuenberger, G. Stoecklin, M. Mallaun, B. Gross, R. Gherzi, D. Hess, B. A. Hemmings, and C. Moroni. 2004. The ARE-dependent mRNA-destabilizing activity of BRF1 is regulated by protein kinase B. EMBO J. 23:4760-4769.
10. Shim, J., H. Lim, J. R. Yates, and M. Karin. 2002. Nuclear export of NF90 is required for interleukin-2 mRNA stabilization. Mol. Cell. 10:1331-1344.
11. Vumbaca, F., K. N. Phoenix, D. Rodriguez-Pinto, D. K. Han, and K. P. Claffey. 2008. Double-stranded RNA-binding protein regulates vascular endothelial growth factor mRNA stability, translation, and breast cancer angiogenesis. Mol. Cell. Biol. 28:772-783.
12. Kuwano, Y., H. H. Kim, K. Abdelmohsen, R. Pullmann, Jr., J. L. Martindale, X. Yang, and M. Gorospe. 2008. MKP-1 mRNA stabilization and translational control by RNA-binding proteins HuR and NF90. Mol. Cell. Biol. 28:4562-4575.
13. Shi, L., G. Zhao, D. Qiu, W. R. Godfrey, H. Vogel, T. A. Rando, H. Hu, and P. N. Kao. 2005. NF90 regulates cell cycle exit and terminal myogenic differentiation by direct binding to the 39-untranslated region of MyoD and p21WAF1/CIP1 mRNAs. J. Biol. Chem. 280:18981-18989.
14. Larcher, J. C., L. Gasmi, W. Viranaïcken, B. Eddé, R. Bernard, I. Ginzburg, and P. Denoulet. 2004. Ilf3 and NF90 associate with the axonal targeting element of Tau mRNA. FASEB J. 18:1761-1763.
15. Kao, P. N., L. Chen, G. Brock, J. Ng, J. Kenny, A. J. Smith, and B. Corthésy. 1994. Cloning and expression of cyclosporin A-and FK506-sensitive nuclear factor of activated T-cells: NF45 and NF90. J. Biol. Chem. 269:20691-20699.
16. Corthésy, B., and P. N. Kao. 1994. Purification by DNA affinity chromatography of two polypeptides that contact the NF-AT DNA binding site in the interleukin 2 promoter. J. Biol. Chem. 269:20682-20690.
17. Chen, C. Y., F. Del Gatto-Konczak, Z. Wu, and M. Karin. 1998. Stabilization of interleukin-2 mRNA by the c-Jun. NH2-terminal kinase pathway. Science 280:1945-1949.
18. Hahn, S., and C. Moroni. 1994. Modulation of cytokine expression in PB-3c mastocytes by IBMX and PMA. Lymphokine Cytokine Res. 13:247-252.
19. Winzen, R., M. Kracht, B. Ritter, A. Wilhelm, C. Y. Chen, A. B. Shyu, M. Müller, M. Gaestel, K. Resch, and H. Holtmann. 1999. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinaseactivated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18:4969-4980.
20. Wodnar-Filipowicz, A., and C. Moroni. 1990. Regulation of interleukin 3 mRNA expression in mast cells occurs at the posttranscriptional level and is mediated by calcium ions. Proc. Natl. Acad. Sci. USA 87:777-781.
21. Durand, D. B., J. P. Shaw, M. R. Bush, R. E. Replogle, R. Belagaje, and G. R. Crabtree. 1988. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8:1715-1724.
22. 647 in response to CD28 costimulation. J. Immunol. 180:222-229.
23. Nishizuka, Y. 1984. Turnover of inositol phospholipids and signal transduction. Science 225:1365-1370.
24. Berry, N., K. Ase, U. Kikkawa, A. Kishimoto, and Y. Nishizuka. 1989. Human T cell activation by phorbol esters and diacylglycerol analogues. J. Immunol. 143:1407-1413.
25. Genot, E. M., P. J. Parker, and D. A. Cantrell. 1995. Analysis of the role of protein kinase C-α,-ε, and-ζ in T cell activation. J. Biol. Chem. 270:9833-9839.
26. Sun, Z., C. W. Arendt, W. Ellmeier, E. M. Schaeffer, M. J. Sunshine, L. Gandhi, J. Annes, D. Petrzilka, A. Kupfer, P. L. Schwartzberg, and D. R. Littman. 2000. PKC-θ is required for TCR-induced NF-kB activation in mature but not immature T lymphocytes. Nature 404:402-407.
27. Monks, C. R., H. Kupfer, I. Tamir, A. Barlow, and A. Kupfer. 1997. Selective modulation of protein kinase C-θ during T-cell activation. Nature 385:83-86.
28. Werlen, G., E. Jacinto, Y. Xia, and M. Karin. 1998. Calcineurin preferentially synergizes with PKC-θ to activate JNK and IL-2 promoter in T lymphocytes. EMBO J. 17:3101-3111.
29. Ghaffari-Tabrizi, N., B. Bauer, A. Villunger, G. Baier-Bitterlich, A. Altman, G. Utermann, F. Uberall, and G. Baier. 1999. Protein kinase Cθ, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells. Eur. J. Immunol. 29:132-142.
30. Altman, A., N. Isakov, and G. Baier. 2000. Protein kinase Cθ: a new essential superstar on the T-cell stage. Immunol. Today 21:567-573.
31. Guo, N. L., Y. W. Wan, K. Tosun, H. Lin, Z. Msiska, D. C. Flynn, S. C. Remick, V. Vallyathan, A. Dowlati, X. Shi, et al. 2008. Confirmation of gene expressionbased prediction of survival in non-small cell lung cancer. Clin. Cancer Res. 14:8213-8220.
32. Dreikhausen, U. E., K. Gorf, K. Resch, and M. Szamel. 2003. Protein kinase Cβ1, a major regulator of TCR-CD28-activated signal transduction leading to IL-2 gene transcription and secretion. Int. Immunol. 15:1089-1098.
33. Long, A., D. Kelleher, S. Lynch, and Y. Volkov. 2001. Cutting edge: protein kinase Cβ expression is critical for export of IL-2 from T cells. J. Immunol. 167:636-640.
34. Yano, H., S. Nakanishi, K. Kimura, N. Hanai, Y. Saitoh, Y. Fukui, Y. Nonomura, and Y. Matsuda. 1993. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268:25846-25856.
35. Huber, M., C. D. Helgason, J. E. Damen, L. Liu, R. K. Humphries, and G. Krystal. 1998. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc. Natl. Acad. Sci. USA 95:11330-11335.
36. Nechushtan, H., M. Leitges, C. Cohen, G. Kay, and E. Razin. 2000. Inhibition of degranulation and interleukin-6 production in mast cells derived from mice deficient in protein kinase Cβ. Blood 95:1752-1757.
37. Nambiar, M. P., C. U. Fisher, A. Kumar, C. G. Tsokos, V. G. Warke, and G. C. Tsokos. 2003. Forced expression of the Fc receptor γ-chain renders human T cells hyperresponsive to TCR/CD3 stimulation. J. Immunol. 170:2871-2876.
38. Nishizuka, Y. 1984. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308:693-698.
39. Weiss, A., J. Imboden, D. Shoback, and J. Stobo. 1984. Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium. Proc. Natl. Acad. Sci. USA 81:4169-4173.
40. Weiss, A., R. L. Wiskocil, and J. D. Stobo. 1984. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J. Immunol. 133:123-128.
41. 2+ ionophore on phorbol myristate acetate co-stimulated cells. Clin. Exp. Immunol. 69:433-440.
42. Zhou, F. F., Y. Xue, G. L. Chen, and X. Yao. 2004. GPS: a novel group-based phosphorylation predicting and scoring method. Biochem. Biophys. Res. Commun. 325:1443-1448.
43. Xue, Y., F. Zhou, M. Zhu, K. Ahmed, G. Chen, and X. Yao. 2005. GPS: a comprehensive www server for phosphorylation sites prediction. Nucleic Acids Res. 33 (Web Server issue): W184-W187.
44. Xue, Y., J. Ren, X. Gao, C. Jin, L. Wen, and X. Yao. 2008. GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy. Mol. Cell. Proteomics 7:1598-1608.
45. Nishizuka, Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614.
46. Szamel, M., A. Appel, R. Schwinzer, and K. Resch. 1998. Different protein kinase C isoenzymes regulate IL-2 receptor expression or IL-2 synthesis in human lymphocytes stimulated via the TCR. J. Immunol. 160:2207-2214.
47. Szamel, M., F. Bartels, and K. Resch. 1993. Cyclosporin A inhibits T cell receptor-induced interleukin-2 synthesis of human T lymphocytes by selectively preventing a transmembrane signal transduction pathway leading to sustained activation of a protein kinase C isoenzyme, protein kinase C-β. Eur. J. Immunol. 23:3072-3081.
48. Thuille, N., T. Gruber, G. Böck, M. Leitges, and G. Baier. 2004. Protein kinase Cb is dispensable for TCR-signaling. Mol. Immunol. 41:385-390.
49. Reichman, T. W., and M. B. Mathews. 2003. RNA binding and intramolecular interactions modulate the regulation of gene expression by nuclear factor 110. RNA 9:543-554.
50. Shi, L., W. R. Godfrey, J. Lin, G. Zhao, and P. N. Kao. 2007. NF90 regulates inducible IL-2 gene expression in T cells. J. Exp. Med. 204:971-977.